Published in Br J Cancer on January 01, 1998
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Cancer Res (2009) 1.91
Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas. Cancer Res (2010) 1.23
A novel fluorescence-based assay for the rapid detection and quantification of cellular deoxyribonucleoside triphosphates. Nucleic Acids Res (2011) 1.21
From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Invest New Drugs (2006) 0.97
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer. Invest New Drugs (2014) 0.92
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. Oncotarget (2015) 0.79
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia. Invest New Drugs (2010) 0.76
Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem (1988) 4.79
LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res (1997) 2.83
A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem (1979) 2.13
A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5- yl)ethyl]benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthase. J Med Chem (1992) 1.38
The effect of methotrexate on intracellular folate pools in human MCF-7 breast cancer cells. Evidence for direct inhibition of purine synthesis. J Biol Chem (1986) 1.17
Evaluation of ascorbic acid in protecting labile folic acid derivatives. Proc Natl Acad Sci U S A (1983) 1.10
Folate-based thymidylate synthase inhibitors as anticancer drugs. Ann Oncol (1995) 1.09
High-dose methotrexate: a critical reappraisal. J Clin Oncol (1987) 1.04
Purification and properties of serine hydroxymethyltransferase and C1-tetrahydrofolate synthase from L1210 cells. J Biol Chem (1990) 1.00
AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies. Cancer Chemother Pharmacol (1996) 1.00
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation. J Clin Oncol (1995) 1.00
Purine modulation of methotrexate cytotoxicity in mammalian cell lines. Cancer Res (1982) 0.99
Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells. Biochem Pharmacol (1983) 0.96
A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors. Cancer Res (1994) 0.95
dNTP pools imbalance as a signal to initiate apoptosis. Experientia (1996) 0.95
Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol. Invest New Drugs (1996) 0.94
Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine. Cancer Res (1979) 0.91
Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs. Mol Pharmacol (1995) 0.89
Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells. Biochem Pharmacol (1996) 0.89
Metabolism and mechanism of action of 5-fluorodeoxycytidine. Proc Natl Acad Sci U S A (1982) 0.88
(6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells. Cancer Res (1991) 0.88
DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine. Br J Cancer (1992) 0.85
Effect of methotrexate on intracellular folate pools in purified myeloid precursor cells from normal human bone marrow. J Clin Invest (1987) 0.83
5,10-Dideazatetrahydrofolic acid reduces toxicity and deoxyadenosine triphosphate pool, expansion in cultured L1210 cells treated with inhibitors of thymidylate synthase. Biochem Pharmacol (1995) 0.79
Newer antifolates in cancer therapy. Prog Drug Res (1995) 0.79
Evidence for a localized conversion of endogenous tetrahydrofolate cofactors to dihydrofolate as an important element in antifolate action in murine leukemia cells. Biochem Pharmacol (1990) 0.78
Compartmentation of intracellular folates. Failure to interconvert tetrahydrofolate cofactors to dihydrofolate in mitochondria of L1210 leukemia cells treated with trimetrexate. Biochem Pharmacol (1991) 0.78
The development of new chemotherapeutic agents. Anticancer Drugs (1996) 0.77
Biochemical and cell cycle perturbations in methotrexate-treated cells. Mol Pharmacol (1982) 0.77
A pigment-binding protein essential for regulation of photosynthetic light harvesting. Nature (2000) 6.97
Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell (1982) 6.93
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature (1982) 6.09
Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A (1979) 5.32
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature (1981) 4.72
Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development (2000) 3.70
Keratin cytoskeletons in epithelial cells of internal organs. Proc Natl Acad Sci U S A (1979) 3.45
Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod (2000) 3.33
LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res (1997) 2.83
Three different human tumor cell lines contain different oncogenes. Cell (1981) 2.77
Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo. Dev Biol (1997) 2.42
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell (1982) 2.22
Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob Agents Chemother (2001) 2.22
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res (2000) 2.18
Trophic conversion of an obligate photoautotrophic organism through metabolic engineering. Science (2001) 2.10
Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis. Dev Biol (1983) 2.03
Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: report of seven new cases and a review of literature. J Neurol (2001) 2.02
Functional identity between murine gamma interferon and macrophage activating factor. Nature (1983) 1.89
Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst (1974) 1.86
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release (2001) 1.85
Preimplantation development of mouse embryos in KSOM: augmentation by amino acids and analysis of gene expression. Mol Reprod Dev (1995) 1.83
Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem (1995) 1.78
The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol (1999) 1.76
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A (1983) 1.67
Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts. Oncol Res (1993) 1.67
Histone macroH2A1 is concentrated in the inactive X chromosome of female preimplantation mouse embryos. Development (2000) 1.66
Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest (1984) 1.65
Interferon: an inducer of macrophage activation by polyanions. Science (1977) 1.59
Oncogene from human EJ bladder carcinoma is located on the short arm of chromosome 11. Science (1983) 1.58
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. J Biol Chem (1984) 1.56
Apoptosis during mouse blastocyst formation: evidence for a role for survival factors including transforming growth factor alpha. Biol Reprod (1997) 1.55
Expression microarray hybridization kinetics depend on length of the immobilized DNA but are independent of immobilization substrate. Anal Biochem (2001) 1.52
Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science (1978) 1.51
RNAi in mouse oocytes and preimplantation embryos: effectiveness of hairpin dsRNA. Biochem Biophys Res Commun (2001) 1.49
Elevated threshold for thyrotropin suppression in congenital hypothyroidism. Am J Dis Child (1980) 1.48
Morphometric variations of the lumbar vertebrae between Chinese and Indian adults. Acta Anat (Basel) (1992) 1.46
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript. J Virol (1990) 1.43
Photoprotection in a zeaxanthin- and lutein-deficient double mutant of Arabidopsis. Photosynth Res (2001) 1.42
Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol (2000) 1.41
Maturation of mouse oocytes in serum-free medium. Hum Reprod (1996) 1.40
Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen. J Virol (1999) 1.39
Inhibition of glycinamide ribonucleotide formyltransferase results in selective inhibition of macrophage cytokine secretion in vitro and in vivo efficacy in rat adjuvant arthritis. Clin Exp Rheumatol (2005) 1.38
A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5- yl)ethyl]benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthase. J Med Chem (1992) 1.38
Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA). Adv Enzyme Regul (1998) 1.37
Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression? Pharmacol Ther (1991) 1.35
Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2. Immunity (1995) 1.34
Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands. J Med Chem (1992) 1.32
Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology (1995) 1.32
Pregenomic RNA encapsidation analysis of eleven missense and nonsense polymerase mutants of human hepatitis B virus. J Virol (1991) 1.30
Expression of MSY2 in mouse oocytes and preimplantation embryos. Biol Reprod (2001) 1.30
Biological characterization of a new radioactive labeling reagent for bacterial penicillin-binding proteins. Antimicrob Agents Chemother (1990) 1.29
Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ (1997) 1.29
Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes. Dev Biol (1994) 1.28
Embryonic genome activation. Front Biosci (2001) 1.28
Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514. Anticancer Res (1999) 1.28
Inner cell mass-specific expression of a cell adhesion molecule (PECAM-1/CD31) in the mouse blastocyst. Dev Biol (2001) 1.27
Dislocation after total hip arthroplasty. Arch Orthop Trauma Surg (1999) 1.25
Regulation of zygotic gene activation in the preimplantation mouse embryo: global activation and repression of gene expression. Biol Reprod (2001) 1.24
Involvement of cAMP-dependent protein kinase and protein phosphorylation in regulation of mouse oocyte maturation. Dev Biol (1986) 1.23
Functional and morphologic characteristics of interferon-treated macrophages. Cell Immunol (1978) 1.23
A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L). J Virol (2000) 1.22
Mouse sperm-egg plasma membrane interactions: analysis of roles of egg integrins and the mouse sperm homologue of PH-30 (fertilin) beta. J Cell Sci (1995) 1.21
Characterization of the binding of recombinant mouse sperm fertilin beta subunit to mouse eggs: evidence for adhesive activity via an egg beta1 integrin-mediated interaction. Dev Biol (1997) 1.20
Regulation of gene expression in the mouse oocyte and early preimplantation embryo: developmental changes in Sp1 and TATA box-binding protein, TBP. Development (1994) 1.20
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin. Anticancer Res (1995) 1.20
Analysis of gene expression in the preimplantation mouse embryo: use of mRNA differential display. Proc Natl Acad Sci U S A (1994) 1.19
Specific macrophage immunity to vaccinia virus: macrophage-virus interaction. Infect Immun (1972) 1.19
Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. J Med Chem (1996) 1.18
Expression patterns of novel genes during mouse preimplantation embryogenesis. Mol Reprod Dev (1994) 1.18
Surgical anatomy of the mandibular ramus of the facial nerve in Chinese adults. Acta Anat (Basel) (1991) 1.18
cis rescue of a mutated reverse transcriptase gene of human hepatitis B virus by creation of an internal ATG. J Virol (1990) 1.17
Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry (1993) 1.16
Active Site of alpha-Chymotrypsin Activation by Association-Desolvation. Proc Natl Acad Sci U S A (1970) 1.16
Egg-induced modifications of the zona pellucida of mouse eggs: effects of microinjected inositol 1,4,5-trisphosphate. Dev Biol (1989) 1.16
Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis. Semin Oncol (1999) 1.16
Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis. Cancer Chemother Pharmacol (1997) 1.15
Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma. Cancer Res (1999) 1.12
Fetuin inhibits zona pellucida hardening and conversion of ZP2 to ZP2f during spontaneous mouse oocyte maturation in vitro in the absence of serum. Biol Reprod (1990) 1.12
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene (1993) 1.12
Reporter gene expression in G2 of the 1-cell mouse embryo. Dev Biol (1993) 1.11
Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation. J Virol (1998) 1.10
Trinucleotide repeat length and progression of illness in Huntington's disease. J Med Genet (1994) 1.10
Temporally restricted spatial localization of acetylated isoforms of histone H4 and RNA polymerase II in the 2-cell mouse embryo. Development (1995) 1.09
Biochemical studies of mammalian oogenesis: synthesis and stability of various classes of RNA during growth of the mouse oocyte in vitro. Dev Biol (1981) 1.08
Igf2r and Igf2 gene expression in androgenetic, gynogenetic, and parthenogenetic preimplantation mouse embryos: absence of regulation by genomic imprinting. Genes Dev (1994) 1.08
Stage-specific expression of a family of proteins that are major products of zygotic gene activation in the mouse embryo. Dev Biol (1991) 1.08
Spontaneous activation of ovulated mouse eggs: time-dependent effects on M-phase exit, cortical granule exocytosis, maternal messenger ribonucleic acid recruitment, and inositol 1,4,5-trisphosphate sensitivity. Biol Reprod (1997) 1.07
Acquisition of a transcriptionally permissive state during the 1-cell stage of mouse embryogenesis. Dev Biol (1992) 1.07
A defective interference-like phenomenon of human hepatitis B virus in chronic carriers. J Virol (1998) 1.07